2m 2m 2m 2m 2m 2m 2m
CUE BIOPHARMA (CUE)
NASDAQ
$26.50-$2.12 (-7.42%)
Price as of Jun 03, 2026 7:04 PM EDT- $74.9MMarket Cap
- 51.02%1-Year Change
- BiotechnologyIndustry
CUE BIOPHARMA (CUE)
$26.50-$2.12 (-7.42%)
CUE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $28.62 | ||
Change | +$4.56 (+18.93%) | ||
Open | $24.97 | ||
High | $29.04 | ||
Low | $24.80 | ||
Previous Close | $24.07 | ||
Volume | 119,827 | ||
30-Day Average Volume | 277,575 | ||
1-Week Change | 42.89% | ||
1-Month Change | -5.92% | ||
1-Year Change | 51.02% | ||
3-Year Change | -76.79% | ||
5-Year Change | -93.16% | ||
Fundamentals | |||
Shares Outstanding | 3.3M | ||
Total Assets | $30.9M | ||
Market Cap | $74.9M | ||
Enterprise Value | $68.5M | ||
Period: QTR TTM FY | |||
Revenue | $5.7M | ||
Net Income | -$5.2M | ||
Free Cash Flow | -$11.1M | ||
EBIT | -$5.2M | ||
EBITDA | -$4.6M | ||
Net Working Capital | $19.0M | ||
EPS | -$32.40 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | 12 | ||
P/B | 3 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -7 | ||
Price/Operating Cash Flow | -7 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 04/24/2026 | ||